Cite
Longitudinal monitoring of cell-free DNA methylation in ALK-positive non-small cell lung cancer patients.
MLA
Janke, Florian, et al. “Longitudinal Monitoring of Cell-Free DNA Methylation in ALK-Positive Non-Small Cell Lung Cancer Patients.” Clinical Epigenetics, vol. 14, no. 1, Dec. 2022, pp. 1–15. EBSCOhost, https://doi.org/10.1186/s13148-022-01387-4.
APA
Janke, F., Angeles, A. K., Riediger, A. L., Bauer, S., Reck, M., Stenzinger, A., Schneider, M. A., Muley, T., Thomas, M., Christopoulos, P., & Sültmann, H. (2022). Longitudinal monitoring of cell-free DNA methylation in ALK-positive non-small cell lung cancer patients. Clinical Epigenetics, 14(1), 1–15. https://doi.org/10.1186/s13148-022-01387-4
Chicago
Janke, Florian, Arlou Kristina Angeles, Anja Lisa Riediger, Simone Bauer, Martin Reck, Albrecht Stenzinger, Marc A. Schneider, et al. 2022. “Longitudinal Monitoring of Cell-Free DNA Methylation in ALK-Positive Non-Small Cell Lung Cancer Patients.” Clinical Epigenetics 14 (1): 1–15. doi:10.1186/s13148-022-01387-4.